Phospholipase D and cancer metastasis: A focus on exosomes.
Fiche publication
Date publication
octobre 2022
Journal
Advances in biological regulation
Auteurs
Membres identifiés du Cancéropôle Est :
Dr GASMAN Stéphane, Dr VITALE Nicolas
Tous les auteurs :
Wolf A, Tanguy E, Wang Q, Gasman S, Vitale N
Lien Pubmed
Résumé
In mammals, phospholipase D (PLD) enzymes involve 6 isoforms, of which only three have established lipase activity to produce the signaling lipid phosphatidic acid (PA). This phospholipase activity has been postulated to contribute to cancer progression for over three decades now, but the exact mechanisms involved have yet to be uncovered. Indeed, using various models, an altered PLD activity has been proposed altogether to increase cell survival rate, promote angiogenesis, boost rapamycin resistance, and favor metastasis. Although for some part, the molecular pathways by which this increase in PA is pro-oncogenic are partially known, the pleiotropic functions of PA make it quite difficult to distinguish which among these simple signaling pathways is responsible for each of these PLD facets. In this review, we will describe an additional potential contribution of PA generated by PLD1 and PLD2 in the biogenesis, secretion, and uptake of exosomes. Those extracellular vesicles are now viewed as membrane vehicles that carry informative molecules able to modify the fate of receiving cells at distance from the original tumor to favor homing of metastasis. The perspectives for a better understanding of these complex role of PLDs will be discussed.
Mots clés
Extracellular vesicles, Metastasis, Multivesicular bodies, Phosphatidic acid, Phospholipase D, Tumor
Référence
Adv Biol Regul. 2022 10 14;:100924